All In Biotech

Free tool

FAERS Monitor: Prepidil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019617 or its brand name (Prepidil, Dinoprostone). Reports on generic versions are filed under their own applications.

Reports

516

Serious

499

97% of reports

Hospitalization

145

Death reported

38

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy118
  • exposure during pregnancy56
  • maternal exposure during pregnancy45
  • off label use35
  • premature baby35
  • haemoglobin decreased34
  • premature delivery32
  • white matter lesion30
  • hypospadias26
  • disseminated intravascular coagulation25
  • foetal anaemia24
  • small for dates baby24
  • neonatal asphyxia23
  • uterine tachysystole21
  • premature separation of placenta20

Reports by year received

View as table
YearReports
20043
20051
200613
20073
20082
20098
201010
20119
201210
201320
20145
20158
201616
201716
201837
201911
202016
202149
202266
202386
202447
202546
202634

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,643 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
foetal anaemiaSignal249151.85928.4171,968
uterine tachysystoleSignal216910.04386.7118,220
neonatal asphyxiaSignal231368.0911.129,091
white matter lesionSignal30991.9697.828,036
premature separation of placentaSignal20536.9348.310,037
hypospadiasSignal26516.0353.912,694
small for dates babySignal24198.0133.94,489
premature deliverySignal3282.158.72,479
disseminated intravascular coagulationSignal2572.549.51,691
foetal exposure during pregnancySignal11859.350.66,716
premature babySignal3547.534.51,546
exposure during pregnancySignal5636.828.71,916
maternal exposure during pregnancySignal4520.615.6822
haemoglobin decreasedSignal3413.59.8383
off label use351.61.28

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.